Patient Rebate Program for REMICADE®
|You may be eligible for a rebate from Janssen CarePath Savings Program for REMICADE® if you:Are beginning or are currently receiving treatment with REMICADE®
Currently have commercial insurance that covers a portion of medication costs for REMICADE®
Have a medication out-of-pocket expense greater than $5 per infusion
Once you’ve completed the one-step enrollment and submitted the necessary documentation to receive your rebate, you can use your card from Janssen CarePath Savings Program toward your medication out-of-pocket costs. Janssen CarePath rebates are determined by medication costs only. Rebate amounts are not determined by costs associated with administration of the IV infusion.
If you think you may be eligible, submit a Janssen CarePath Savings Program enrollment form today. Other eligibility requirements may apply. To learn more about Janssen CarePath, visit Remicade.JanssenCarePathSavings.com.
Medication rebate for people receiving or beginning treatment with REMICADE® (infliximab)
Based upon your eligibility, CarePath® can provide a rebate for your medication out-of-pocket costs, including deductible, co-payment, and co-insurance, for up to 12 months, for a maximum annual benefit of $10,000.
Am I eligible for a RemiStart® rebate?
You may be eligible for a rebate from RemiStart® if you:
- Are beginning or are currently receiving treatment with REMICADE®
- Currently have commercial insurance that covers medication costs for REMICADE®
- Have a medication out-of-pocket expense greater than $5 per infusion
Please click here for other Restrictions which may apply.
The cost of IV infusion services are not covered by this program.